Finance

Lists
NAGE:NASDAQ
Niagen Bioscience Inc
2,69 US$
+1,13%
(+0,030) 1D
2,69 US$
0,00% (0,00)
After hours
Closed: 9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
2,68 US$
High
2,71 US$
Low
2,66 US$
Mkt. cap
214,54 მლნ.
Avg. vol.
486,42 ათ.
Volume
268,12 ათ.
52-wk high
7,95 US$
52-wk low
2,61 US$
Beta
2,02
Shares outstanding
79,13 მლნ.
No. of employees
117
Open
2,68 US$
High
2,71 US$
Low
2,66 US$
Mkt. cap
214,54 მლნ.
Avg. vol.
486,42 ათ.
Volume
268,12 ათ.
52-wk high
7,95 US$
52-wk low
2,61 US$
Beta
2,02
Shares outstanding
79,13 მლნ.
No. of employees
117
News stories
From web sources and news partners
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
Headquartersლოს-ანჯელესი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorPersonal care products
Websiteniagenbioscience.com
Analyst ratings
Based on 4 analysts giving stock ratings to NAGE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NAGE in the last 3 months.
Highest
Current 2,69 US$
11,00 US$ (+308,92%)
Average
10,50 US$ (+290,33%)
Lowest
10,00 US$ (+271,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Buy
Reiterated
10,00 US$
+271,7%
10/05/2026
Sean McGowan
Roth MKM
Buy
Maintained
10,00 US$
+271,7%
08/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
11,00 US$
+308,9%
08/05/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
11,00 US$
+308,9%
07/21/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
9,00 US$
+234,6%
07/06/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
12,00 US$
+346,1%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
33,99 მლნ.
33,84 მლნ.
31,47 მლნ.
29,78 მლნ.
Cost of goods sold
12,06 მლნ.
12,14 მლნ.
11,50 მლნ.
10,47 მლნ.
Cost of revenue
12,06 მლნ.
12,14 მლნ.
11,50 მლნ.
10,47 მლნ.
Research and development expenses
1,80 მლნ.
1,71 მლნ.
1,48 მლნ.
1,51 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 მლნ.
17,89 მლნ.
16,92 მლნ.
17,10 მლნ.
Operating expense
17,69 მლნ.
19,60 მლნ.
18,40 მლნ.
18,61 მლნ.
Total operating expenses
29,75 მლნ.
31,74 მლნ.
29,90 მლნ.
29,08 მლნ.
Operating income
4,24 მლნ.
2,10 მლნ.
1,58 მლნ.
700,00 ათ.
Other non operating income
-
-214,00 ათ.
-
-
EBT including unusual items
4,80 მლნ.
4,42 მლნ.
6,74 მლნ.
1,07 მლნ.
EBT excluding unusual items
4,80 მლნ.
2,44 მლნ.
1,95 მლნ.
1,07 მლნ.
Income tax expense
222,00 ათ.
292,00 ათ.
417,00 ათ.
106,00 ათ.
Effective tax rate
4,62%
6,60%
6,19%
9,92%
Other operating expenses
-
-
-
-
Net income
4,58 მლნ.
4,13 მლნ.
6,32 მლნ.
963,00 ათ.
Net profit margin
13,47%
12,21%
20,07%
3,23%
Earnings per share
0,05
0,03
0,02
0,01
Interest and investment income
564,00 ათ.
552,00 ათ.
375,00 ათ.
372,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
564,00 ათ.
552,00 ათ.
375,00 ათ.
372,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
4,43 მლნ.
2,30 მლნ.
1,87 მლნ.
991,00 ათ.
Gain or loss from assets sale
-
-
-4,78 მლნ.
26,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები